Versant Venture Capital Iii, L.p.

Affiliations

  • Large Shareholder at Skye Bioscience Inc. (SKYE), 2023-08-28
  • Large Shareholder at Flexion Therapeutics Inc (FLXN), 2016-06-11
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-24
  • Large Shareholder at Ocular Therapeutix Inc (OCUL), 2015-06-15
  • Large Shareholder at Opgen Inc (OPGN,OPGNW), 2015-05-12
  • Large Shareholder at Immune Design Corp. (IMDZ), 2014-07-31
  • Large Shareholder at Veracyte Inc. (VCYT), 2013-11-05
  • Large Shareholder at Trius Therapeutics Inc (TSRX), 2010-08-10
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IMDZ $12.00 233,333 $2,799,996.00 2,208,210 2014-07-29 Filing
FLXN $13.00 1,806 $23,478.00 3,206,807 2014-02-18 Filing
FLXN $13.00 305,886 $3,976,518.00 3,205,001 2014-02-18 Filing
TSRX $5.00 914,529 $4,572,645.00 3,235,839 2010-08-06 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OCUL $22.00 1,878 $41,316.00 13,007 2015-06-15 Filing
OCUL $22.00 318,122 $6,998,684.00 2,202,377 2015-06-15 Filing
OCUL $22.00 2,506 $55,132.00 14,885 2015-06-10 Filing
OCUL $22.00 424,494 $9,338,868.00 2,520,499 2015-06-10 Filing
IMDZ $12.00 208,334 $2,500,008.00 1,974,877 2014-07-29 Filing